| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Epidemiology and Population Health (R.C.K., A.P.M., H.D.S., T.E.R., X.X.), Albert Einstein College of Medicine, Bronx, New York 10461; Cancer Prevention Research Unit, Departments of Medicine and Oncology (M.N.P.), Lady Davis Research Institute of Jewish General Hospital and McGill University, Montreal, Quebec, Canada H3T 1E2; Department of Medicine and Epidemiology (L.H.K.), University of Pittsburgh, Pittsburgh, Pennsylvania 15261; Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine (A.R.C.), University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104; and Departments of Epidemiology, Medicine and Health Services, Cardiovascular Health Research Unit (B.M.P.), University of Washington, Seattle, Washington 98101
Address all correspondence and requests for reprints to: Robert C. Kaplan, Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Belfer 1306C, Bronx, New York 10461. E-mail: rkaplan{at}aecom.yu.edu.
Context: Prior observational studies have demonstrated that the GH/IGF axis is associated with cardiovascular disease. However, this association has not been extensively studied among older adults.
Objective: The objective of this study was to assess the association between levels of total IGF-I and IGF binding proteins (IGFBP-1, IGFBP-3) and risk of incident coronary events and ischemic stroke.
Design and Participants: A case-cohort analysis was conducted among adults 65 yr and older in the Cardiovascular Health Study.
Main Outcome Measures: A total of 534 coronary events [316 nonfatal myocardial infarctions (MIs), 48 fatal MIs, and 170 fatal coronary heart disease events] and 370 ischemic strokes were identified on follow-up. Comparison subjects were 1122 randomly selected participants from the Cardiovascular Health Study.
Results: Mean follow-up time was 6.7 yr for coronary events, 5.6 yr for strokes, and 9.3 yr for comparison subjects. Hazard ratios (95% confidence intervals) associated with baseline levels of total IGF-I and IGFBPs were estimated using multivariate adjusted Cox proportional hazards models. Neither IGF-I nor IGFBP-1 levels predicted risk of incident coronary events or stroke. IGFBP-3 had an inverse association with risk of coronary events [adjusted hazard ratio per SD = 0.88 (0.781.00), P = 0.05] but was not associated with stroke. Exploratory analyses suggested that low IGF-I and low IGFBP-3 levels were significantly associated with higher risk of nonfatal MI (P < 0.05) but not with risk of fatal MI or fatal coronary heart disease.
Conclusion: Circulating levels of total IGF-I or IGFBP-1 were not associated with risk of total coronary events or ischemic stroke among older adults, whereas low IGFBP-3 level was associated with increased risk of incident coronary events.
This article has been cited by other articles:
![]() |
J. H. Page, J. Ma, M. Pollak, J. E. Manson, and S. E. Hankinson Plasma Insulinlike Growth Factor 1 and Binding-Protein 3 and Risk of Myocardial Infarction in Women: A Prospective Study Clin. Chem., October 1, 2008; 54(10): 1682 - 1688. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Perticone, A. Sciacqua, M. Perticone, I. Laino, S. Miceli, I. Care', G. Galiano Leone, F. Andreozzi, R. Maio, and G. Sesti Low-Plasma Insulin-Like Growth Factor-I Levels Are Associated with Impaired Endothelium-Dependent Vasodilatation in a Cohort of Untreated, Hypertensive Caucasian Subjects J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2806 - 2810. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |